Cure My Disease

Don't miss your cure!

 Log in / Sign up

New ICU energy tracker put to the test against gold standard

NCT ID NCT07165080

Knowledge-focused Sponsor: ART Medical Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new tool called smART+ REE Module to see how well it calculates resting energy expenditure (calories burned at rest) in ICU patients on ventilators. Researchers compared it to an already-approved device (Q-NRG+) in 40 adults. The goal was to check if the new tool is accurate enough for hospital use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

40 people

The number who actually took part.

Started

Aug 2025

Finished

Oct 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Due to the anticipated dropout rate after one or two measurement rounds, we plan to recruit a minimum of 25 patients and up to 40 patients. Each patient will undergo a maximum of 4 measurement rounds. The study will conclude once 90 measurement rounds have been completed, regardless of the number of patients remaining in the study at that point. All patients enrolled in the study will be mechanically ventilated patients who have already been admitted to the ICU, are eligible for use of the smART+ System and COSMED device, are in a relatively stable condition, and are expected to remain ventilated for at least 24 hours. The study will exclude patients requiring chest drainage, because not all the air exhaled by these patients comes through the ventilator tube (due to the drains collecting air leak), compromising the accuracy of VCO2 measurements.

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Males and females 22 years or older * Patient has already been admitted to ICU * Patient expected to be ventilated at least 24 hours after enrollment * Patients should be stable hemodynamically (no increase/decrease in vasopressors) and respiratory (no change in mechanical ventilation settings) for at least 1 hour prior to initiation of study procedures. Exclusion Criteria: * Women who are pregnant * Patient requiring chest drainage

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Comparative study are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Comparative study REE Resting energy expenditure

Contacts and locations

Locations

  • Beilinson Medical Center

    Petah Tikva, Hasharon, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.